Evidence map›Paper›PMID 28940157›Full record

ArticleCerebellum (London, England)2018

Climbing Fiber Development Is Impaired in Postnatal Car8

Lauren N Miterko, Roy V Sillitoe

Abstract read
In one paragraph

Article in Cerebellum (London, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Lauren N MiterkoDepartment of Pathology and Immunology, Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, 1250 Moursund Street, Suite 1325, Houston, TX, 77030, USA.
Roy V SillitoeDepartment of Pathology and Immunology, Baylor College of Medicine, Jan and Dan Duncan Neurological Research Institute of Texas Children's Hospital, 1250 Moursund Street, Suite 1325, Houston, TX, 77030, USA. sillitoe@bcm.edu.
Baylor College of Medicine · USTexas Children's Hospital · US

Funding

Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI LEE, BRENDAN, NELSON, DAVID LOREN · 2014 to 2019
$7.8M
SYNAPTIC ORIGINS OF CEREBELLAR DISEASER01NS089664 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI SILLITOE, ROY VINCENT · 2014 to 2018
$1.7M
Eunice Kennedy Shriver National Institute of Child Health and Human Development U54HD083092National Institutes of Neurological Disorders and Stroke RO1NS089664NICHD NIH HHS U54 HD083092NINDS NIH HHS R01 NS089664
6 · The paper itself

Abstract

The cerebellum is critical for an array of motor functions. During postnatal development, the Purkinje cells (PCs) guide afferent topography to establish the final circuit. Perturbing PC morphogenesis or activity during development can result in climbing fiber (CF) multi-innervation or mis-patterning. Structural defects during circuit formation typically have long-term effects on behavior as they contribute to the phenotype of movement disorders such as cerebellar ataxia. The Car8

Indexed as

Action PotentialsAge FactorsAnimalsAnimals, NewbornBiomarkers, TumorCalbindinsCarbonic AnhydrasesCerebellumGene Expression Regulation, DevelopmentalMiceMice, Inbred C57BLMice, TransgenicNerve FibersNerve Tissue ProteinsPurkinje CellsVesicular Glutamate Transport Protein 2Biomarkers, TumorCalbindinsCar8 protein, mouseCarbonic AnhydrasesNerve Tissue ProteinsVesicular Glutamate Transport Protein 2AtaxiaCAR8CerebellumCircuitryClimbing fiberDevelopment

Identifiers

PMID28940157
PMCPMC6053913
OpenAlexW2757506735

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.